BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30964)

  • 1. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Data from the study of effort blood pressure profile in hypertensive subjects, before and after treatment].
    Debru JL; Doyon B; Morin B; Perdrix A; Mallion JM
    Nouv Presse Med; 1978 Sep; 7(31):2777-82. PubMed ID: 30963
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the action of pindolol during rest and exertion on a group of subjects with hypertension].
    Debru JL; Mikler F; Grubier M; Cau G; Muller JM; Mallion JM
    Ann Cardiol Angeiol (Paris); 1976 Oct; 25(5):393-7. PubMed ID: 984726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 7. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
    Safar M; Weiss Y; Chau NP; Kheder A; Levenson J; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2759-60. PubMed ID: 30957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical test of a new beta-receptor blockader in labile hypertension].
    Walter I; Kusus T; Lydtin H
    Verh Dtsch Ges Inn Med; 1971; 77():940-3. PubMed ID: 5156091
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
    Barraine R; Bouchez C
    Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pressor reaction of hypertonic subjects to physical exercise of submaximal intensity under the influence of beta-adrenergic block (Pindolol) (author's transl)].
    Chrástek J; Boudová L; Kavánková M; Benes K; Krízek V; Matousek O
    Sb Lek; 1973 Oct; 75(10):301-11. PubMed ID: 4759769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-blockers and arterial hypertension in the aged patient].
    Emeriau JP; Rumeau M
    Nouv Presse Med; 1978 Sep; 7(31):2803-6. PubMed ID: 30969
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of LB 46 on the blood pressure in essential hypertension.
    Duner H
    Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.